Collegium Pharmaceutical (COLL) Forms DEF 14A Filing on April 10
Published on 4/10/2026
AI Summary
Collegium Pharmaceutical (COLL) has filed a DEF 14A with the SEC dated April 10. This filing includes essential information regarding upcoming shareholder meetings and proposals for the company's governance. It is a standard procedure in ensuring compliance with regulatory requirements. Market participants will review this filing to assess any potential impacts on shareholder relations or corporate strategy.
Related News
Regulation
UK Government Plans Under-16 Social Media Restrictions by Year-End
May 25
Regulation
Google (GOOGL) Faces Potential EU Fine in Triple-Digit Millions
May 25
Markets
RXO (NYSE:RXO) Hedge Fund Increases Position by 532,276 Shares
May 25
Regulation
Wells Fargo (WFC) to Pay $100M for Discrimination in Home Loans
May 25